Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?

Best Practice & Research Clinical Gastroenterology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles